Fetal Dependent Patents: An Interim Report
October 5, 2005
This report examines the extent that patents have promoted the commercialization of human fetal organs and other human fetal tissue. The period 1991-2001 saw an explosion in the number of US patents that rely upon or depend upon the ready availablity of fetal tissue in this country.
The report concludes that the United States Patent and Trademark Office should not neglect to enforce the public policy/morality prong of 35 USC 101 in the face of evidence that human body parts have become the subject of issued US Patent claims.
Legal Challenge to U.S. Patenting of Animals (Executive Summary)
February 25, 2004
CTA and the American Anti-Vivisection Society demand the cancellation of a patent granted to the University of Texas for a beagle with a suppressed immune system.
View the Request for Reexamination.
Animal Patenting Fact Sheet
February 24, 2004
Compiled by CTA’s Patent Watch Program and the American Anti-Vivisection Society.
Executive Summary of Patent Watch’s Discovery of the First US Patent for Reproductive Human Cloning
May 16, 2002
Patent Watch discovers that the United States has granted a patent for a human cloning techniques, as well as for any resulting embryos, fetuses, and children.
View the Press Release.
View the Patent.
Biocolonization: The Patenting of Life and the Global Market in Body Parts
July 15, 1996
A chapter written by CTA Executive Director Andrew Kimbrell from The Case Against the Global Economy and a Turn Toward the Local (Sierra Club Books, 1996).